Marketwire - Medical and Healthcare

ZONARE Medical Systems Introduces Advancements for z.one Ultrasound Platform at RSNA

Tue, 02 Dec 2008 09:00:00 EST

New Capabilities Include Solution for Difficult-to-Image Patients, High Resolution Imaging Capabilities, Elastography Applications and 3D Imaging

Elsevier to Host Vaccine Virtual Congress With ON24 Virtual Show

Tue, 02 Dec 2008 09:00:00 EST

Vaccine Virtual Congress Ensures Attendees Can Attend Online to Get Vital Information About Vaccines and Infectious Diseases

OB/GYN Associates of Southern Indiana Increases Productivity and Kept Appointment Rates With ReminderPro Automated Messaging System

Tue, 02 Dec 2008 09:00:00 EST

ReminderPro Provides Improved Patient Relations With Less Than One Month ROI

CLX Medical, Inc. Announces Close of ThyroTest(R) Acquisition

Tue, 02 Dec 2008 08:50:00 EST

MURRIETA, CA--(Marketwire - December 2, 2008) - CLX Medical, Inc. (OTCBB: CLXN), which is focused on the marketing and distribution of unique medical diagnostic testing products, today announced the close of the company's acquisition of ThyroTest�, a rapid thyroid stimulating hormone (TSH) screening device used for the detection of hypothyroidism in adults, a common thyroid disease.

With the close of the transaction, CLX Medical will implement its ThyroTest� marketing program and establish distribution of the product with a national U.S. distributor. ThyroTest� is FDA cleared and has also achieved CLIA waived status, so the test can be administered in the more than 100,000 CLIA waived doctors' offices in the U.S., as well as in any non-waived laboratory.

SK&A Offers Deeper Intelligence on Office-Based Physicians and Their Medical Practices

Tue, 02 Dec 2008 08:15:00 EST

IRVINE, CA--(Marketwire - December 2, 2008) - SK&A, a leading provider of healthcare information solutions and research, today announced it has added important new targeting variables to its market leading Office-Based Physicians database. As part of its standard telephone verification and survey process, SK&A Research Associates are asking medical offices about the primary and secondary languages their office supports, site office hours, the number of exam rooms, whether or not the office accepts Medicare and Medicaid, whether or not the office is accepting new patients, whether or not the office is using an Electronic Medical Records (EMR) system, and office billing address verification.

Canadian Stroke Network: Stroke Guidelines to Fill Gaps in Health Care

Tue, 02 Dec 2008 08:00:00 EST

Action required to save lives and prevent disability

R�seau canadien contre les accidents c�r�brovasculaires : Les lignes directrices en mati�re d'AVC visent � combler les lacunes

Tue, 02 Dec 2008 08:00:00 EST

Pour sauver des vies et pr�venir les handicaps il faut passer � l'action.

Somatic Systems, Inc. Announces Shareholder Conference Date

Tue, 02 Dec 2008 08:00:00 EST

NORTHAMPTON, MA--(Marketwire - December 2, 2008) - Somatic Systems, Inc. (PINKSHEETS: SMAS) will hold its online shareholder conference today, at 4:15 PM Eastern Time. The conference will enable shareholders to communicate directly to the CEO of the company, to get updates and learn more about the company's growth, plans, and activities.

Shareholders can enter the conference at 4:15 PM today via the Somatic Systems' website at http://somatics.org/investors/conference.

REMINDER: Laparoscopic Heller Myotomy Esophagea a Minimally Invasive Surgery to Treat Achalasia

Tue, 02 Dec 2008 07:15:00 EST

OR-Live Webcast From Northwestern Memorial Hospital: December 2, 2008 3:00 PM CST

Countdown to Quit!

Tue, 02 Dec 2008 07:00:00 EST

With New Year's Eve around the corner, smokers planning to quit should get ready NOW

Le compte � rebours pour l'abandon!

Tue, 02 Dec 2008 07:00:00 EST

A l'approche du Nouvel An, les fumeurs qui pr�voient cesser de fumer doivent s'y pr�parer d�s maintenant

Noesis Bursting With Exciting Growth

Tue, 02 Dec 2008 07:00:00 EST

PARSIPPANY, NJ--(Marketwire - December 2, 2008) - Noesis, a professional advertising and promotion unit of CommonHealth whose name is derived from the Greek word meaning "to think," today announced two promotions and three new hires.

CommonHealth (www.commonhealth.com) is the world's leading healthcare-communications network and a WPP (NASDAQ: WPPGY) (www.wpp.com) company.

FirstCare Selects Callidus On-Demand Solution to Automate Compensation and Integrate to Salesforce.com

Tue, 02 Dec 2008 07:00:00 EST

Provider of Health Care Services to Standardize on Industry's Leading SPM Platform

Purespace Cleans Up the Dirtiest Environments

Tue, 02 Dec 2008 06:10:00 EST

LOS ANGELES, CA--(Marketwire - December 2, 2008) - The worst disease-carrying pathogens aren't found in gutters, rivers or skies. Yet every day, nearly all adults and children are exposed to them. People are unknowingly introducing potentially literally millions of germs and bacteria into their systems over and over again simply by entering the bathroom. Bathroom germs and bacteria carried on such basic personal items as tooth and hair brushes, tweezers, pacifiers and baby bottle nipples, break down our natural immune systems. Multiple studies have linked these pathogens to diabetes, heart disease, and even certain cancers. Until now there has not been an effective way to disinfect and protect personal care items in the home, leaving even healthy people open to illness and disease on a daily basis. Purespace is the first of its kind appliance for disinfecting and storing www.nicox.com

NicOx S.A. (NYSE Euronext Paris: COX) today announced it has signed an agreement with DSM for the commercial manufacture and supply of naproxcinod drug substance (or API, active pharmaceutical ingredient). Naproxcinod is NicOx' lead investigational product and the first compound in the Cyclooxygenase-Inhibiting Nitric Oxide-Donating (CINOD) class of anti-inflammatory agents, which recently achieved positive results in the third pivotal phase 3 study in osteoarthritis patients.

MEDIA ADVISORY: Van Nuys Airport's 80th Anniversary Celebration Honors Medical Flight Teams

Tue, 02 Dec 2008 01:04:00 EST

VAN NUYS, CA--(Marketwire - December 2, 2008) -

WHAT:      Van Nuys Airport's 80th anniversary celebration, "Gift of
           Flight," will honor air ambulance operators and flight crews who
           provide time-critical medical transportation to save lives,
           including the Los Angeles Fire Department Air Operations Unit,
           Helinet Aviation and AIRescue International. The dinner event
           will pay special tribute to Helinet Aviation for donating a
           $1.7 million helicopter, six pilots on 24-hour standby,
           insurance and fuel to Childrens Hospital Los Angeles to improve
           medical team response times by 60 percent. Thousands of lives
           have been saved through the heroic, complex and often dangerous
           missions performed by these highly-trained flight crews.

WHEN:      Thursday, Dec. 4, 2008 from 5:30 p.m. to 8:30 p.m.

           5:30 p.m.    Reception and silent auction to benefit

Kearny Ventures Hires Andrew Jensen as Chief Financial Officer

Mon, 01 Dec 2008 19:20:00 EST

SAN FRANCISCO, CA--(Marketwire - December 1, 2008) - Kearny Venture Partners has hired Andrew Jensen as Chief Financial Officer, the firm announced today.

As CFO, Mr. Jensen will oversee investor relations, legal, finance, information technology and human resources, and he will assist the investing team with transaction structuring and financial due diligence. Prior to joining Kearny Ventures, Mr. Jensen was CFO of Liquid Realty Partners, a real-estate secondaries firm, from 2005 to 2008. Before that, he was the Senior Controller of Gryphon Investors and Director of Finance at Sanderling Ventures. Earlier, Mr. Jensen, a certified public accountant, was an audit manager with Arthur Andersen. He has earned his BA in Finance and Accounting with honors from the University of California, Berkeley.

Sun Healthcare Group, Inc. Resets Interest Rate on $154 Million of Bank Term Loans at 4.1 Percent

Mon, 01 Dec 2008 18:00:00 EST

IRVINE, CA--(Marketwire - December 1, 2008) - Sun Healthcare Group, Inc. (NASDAQ: SUNH) today announced that variable interest rates on $154.4 million of its outstanding bank term loans were reset in late Nov. 2008 at an average nominal rate of 4.13 percent. The variable interest rates are based on LIBOR plus a spread of 200 basis points. Interest rates can generally be reset for periods of one month to six months.

At Nov. 30, 2008, the outstanding bank term loans, which mature on April 19, 2014, aggregated $347.0 million. Sun had previously fixed interest rates through July 2010 on $150.0 million of the term loans at an average nominal interest rate of 6.81 percent through interest rate swap arrangements. As a result, at Nov. 30, 2008, the average nominal rate for the outstanding term loans, including the recent reset, is 5.47 percent.

NexgenRx Announces Completion of Private Placement

Mon, 01 Dec 2008 17:31:00 EST

TORONTO, ONTARIO--(Marketwire - Dec. 1, 2008) - NEXGENRX INC. ("NexgenRx" or the "Company") (TSX VENTURE:NXG) is pleased to announce the completion of its $750,000 private placement with the issuance of an aggregate of 250,000 common shares at a price of $0.20 per share for gross proceeds of $50,000 (the remaining $700,000 having been previously issued and announced). This private placement was completed on a non-brokered basis and no finders' fees were paid. In accordance with applicable securities laws, the foregoing common shares are subject to a four-month hold period.

Intrinsyc Optimizes Operations in Response to Market Conditions

Mon, 01 Dec 2008 17:00:00 EST

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Dec. 1, 2008) - Intrinsyc Software International, Inc. (TSX:ICS), a leading provider of mobile and embedded software solutions, today announced that it will implement a comprehensive cost reduction plan designed to preserve cash and working capital through the reduction in operating expenses by approximately US$10 million to US$11 million to approximately US$18 million to US$19 million on an annualized basis, resulting in a substantially reduced revenue breakeven level.

Albeo Technologies Releases 2009 Solid-State Lighting Product Catalog

Mon, 01 Dec 2008 16:04:00 EST

Albeo Delivers a Complete Line of LED Lighting Fixtures for Industrial and Commercial Lighting Applications That Reduce Energy Consumption and Maintenance

Media Advisory: BC Celebrates 20 Years of Heart Transplantation

Mon, 01 Dec 2008 14:44:00 EST

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Dec. 1, 2008) - Media representatives are invited to attend a press conference on Tuesday, December 2. Physicians, heart transplant recipients and representatives from the Province and BC Transplant will gather to celebrate the 20th Anniversary of Heart Transplantation in British Columbia. It has been 20 years since the first heart transplant was performed in British Columbia. Since then, through continued innovation, and collaboration, over 325 life-saving heart transplants have been performed in the Province.

MD&DI Wins National Gold Azbee Award From ASBPE for 'Neurotechnology Article'

Mon, 01 Dec 2008 14:05:00 EST

LOS ANGELES, CA--(Marketwire - December 1, 2008) - Medical Device & Diagnostic Industry (MD&DI), a Canon Communications publication, and Sherrie Conroy, Editor-in-Chief, were recently honored with a prestigious National Gold Azbee award for Best Feature Article in 2007 by the American Society of Business Publication Editors (A.S.B.P.E). The winning article, "Neurotechnology Offers Relief and Recovery," written by Conroy, was published in the July 2007 issue of MD&DI.

SCI Solutions Completes Fiscal Year With Record New Contract Sales

Mon, 01 Dec 2008 13:47:00 EST

Web-Based Access Management Company Hits Milestone Customer

Sierra Systems Contributes to Alberta Premier's Award of Excellence Gold Medal Project

Mon, 01 Dec 2008 12:00:00 EST

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Dec. 1, 2008) - Sierra Systems Group Inc., a leading information technology and consulting services company, announced it was part of a project team that recently received the Alberta Premier's Award of Excellence (PAE) Gold Medal. The Sierra project team was part of the Agricultural Financial Services Corporation's myAFSC Website and Electronic Forms project that was one of only six recipients of the PAE Gold Medal. The PAE recognizes superior client services and business practices in the Alberta public service.

Vanguard Pharmaceutical Corporation Negotiates Telomerase Delivery Technology

Mon, 01 Dec 2008 11:49:00 EST

SAN ANTONIO, TX--(Marketwire - December 1, 2008) - Vanguard Pharmaceutical Corp. (PINKSHEETS: VGPH), a company who has joined the fight against cancer by selling affordable generic oncology drugs and researching noninvasive cures for cancer, is now in negotiations with a biotechnology company who has an effective delivery method for telomerase therapies. Vanguard is negotiating to either acquire or gain a significant stake in the company.

Leatt Corporation Unveils the New ADVenture Brace(TM)

Mon, 01 Dec 2008 11:22:00 EST

A More Cost-Effective Alternative for Safety Conscious Riders

Sagentia Undertakes Full 'Concept Through to Manufacture' Development of Acne Treatment Lamp

Mon, 01 Dec 2008 10:15:00 EST

MAPLE LAWN, MD--(Marketwire - December 1, 2008) - Sagentia (LSE: SAG), the world leading product development, technology consulting and IP exploitation company with U.S. offices in Maple Lawn, Maryland and corporate headquarters in Cambridge, UK, has deployed its full concept through to manufacture service to deliver the rapid development of a new Photodynamic Treatment (PDT) lamp.

Norwegian-based pharmaceutical company Photocure had identified the need for a new, large-area PDT lamp that could be used in combination with its proprietary pharmaceutical Visonac� for the treatment of moderate to severe acne. With time to market and cost of development as key issues, the company recognized that a highly focused development program would be required. The goal was to achieve a production-ready device for planned Phase III clinical trials starting in the first half of 2009.

TeraRecon Introduces iNtuition UNLIMITED(TM) at RSNA 2008

Mon, 01 Dec 2008 10:04:00 EST

SAN MATEO, CA--(Marketwire - December 1, 2008) - TeraRecon, Inc. (www.terarecon.com), a leading provider of advanced visualization software, today unveiled iNtuition UNLIMITED, a flexible licensing program that empowers institutional informatics teams with unlimited access to Aquarius iNtuition software assets, to be deployed as required to meet an institution's evolving needs for advanced visualization.

"iNtuition UNLIMITED removes the traditional limitations of a fixed number of software licenses or hardware assets," said Robert Taylor, Ph.D., TeraRecon president and chief operating officer. "An institution, which may be distributed across many sites or business entities, needs to be able to deploy software on their own hardware, in as many locations as necessary to meet increasing clinical demand, and while overcoming geographical, contractual and network constraints that may shift over time. iNtuition UNLIMITED achieves all this in the

ZONARE Medical Systems Introduces New, Premium Performance Echocardiography Release for z.one Ultra System

Mon, 01 Dec 2008 09:00:00 EST

New Release Incorporates Zone Sonography(TM) Technology and Premium Image Quality for Hospitals and Bedside Studies

Chembio Donates HIV Tests to Support World AIDS Day 2008 Testing Initiative

Mon, 01 Dec 2008 09:00:00 EST

MEDFORD, NY--(Marketwire - December 1, 2008) - Chembio Diagnostics, Inc. (OTCBB: CEMI) ("Chembio" or the "Company") joined AIDS Healthcare Foundation (AHF) in the World AIDS Day 2008 global effort to test one million people from November 26 through December 1, 2008. Based in Los Angeles, AHF provides state-of-the-art medicines and advocacy to over 85,000 people in 22 countries and is the nation's largest provider of HIV/AIDS medical care. Chembio is supporting these efforts by providing approximately 20,000 HIV 1/2 STAT-PAK� tests to testing programs in 3 countries. Chembio's HIV 1/2 STAT-PAK� and HIV 1/2 STAT-PAK� Dipstick tests are ideally suited for point-of-care testing with a simple test protocol, long shelf life, minimum sample requirements for venous or finger-stick whole-blood, plasma or serum, test results in < 10 minutes and room temperature storage requirements. Chembio has also complete

Dr. Farokh Jiveh, of Royal Palm Beach, Florida, Is Announced as a Mentor and Senior Instructor for the California Center for Advanced Dental Studies

Mon, 01 Dec 2008 09:00:00 EST

ROYAL PALM BEACH, FL--(Marketwire - December 1, 2008) - After careful consideration, the California Center for Advanced Dental Studies' (CCADS) board is excited to announce that Dr. Farokh Jiveh has been appointed as a Mentor Senior Instructor. "We are thrilled to have Dr. Jiveh as a Mentor-Senior Instructor. He absolutely possesses all the qualities we look for. He's a premier clinician and an outstanding teacher," said Dr. Thomas Dudney, Program Director of CCADS.

Dr. Jiveh's selection is the result of a rigorous selection process that includes an in-depth look at the doctor's collegiate and post-graduate education, clinical skills and overall integrity. In order to be selected, the dentist must have completed a minimum of 120 hours and three levels of advanced clinical training from accredited post-graduate programs. "What distinguishes our Mentors," comments Garrett Caldwell, President of CCADS, "is their comprehension and use of advanced clinical protocols for ve

Dr. Caitilin Martini, of Tampa, Florida, Is Announced as a Mentor and Senior Instructor for the California Center for Advanced Dental Studies

Mon, 01 Dec 2008 09:00:00 EST

TAMPA, FL--(Marketwire - December 1, 2008) - After careful consideration, the California Center for Advanced Dental Studies' (CCADS) board is excited to announce that Dr. Caitilin Martini, DMD, has been appointed as a Mentor Senior Instructor. "We are thrilled to have Dr. Martini as a Mentor-Senior Instructor. She absolutely possesses all the qualities we look for. She's a premier clinician and an outstanding teacher," said Dr. Thomas Dudney, Program Director of CCADS.

Dr. Martini's selection is the result of a rigorous selection process that includes an in-depth look at the doctor's collegiate and post-graduate education, clinical skills and overall integrity. In order to be selected, the dentist must have completed a minimum of 120 hours and three levels of advanced clinical training from accredited post-graduate programs. "What distinguishes our Mentors," comments Garrett Caldwell, President of CCADS, "is their comprehension and use of advanced clinical protocols for

Healthline Networks Selected as the Exclusive Search and Advertising Partner for Optumhealth's New Consumer Health Portal, www.myOptumHealth.com

Mon, 01 Dec 2008 09:00:00 EST

New Health and Wellness Site Adds to Healthline's Roster of World-Class Search, Content and Advertising Partners

Dr. Larry Saylor, of Brandon, Florida, Is Announced as a Mentor and Senior Instructor for the California Center for Advanced Dental Studies

Mon, 01 Dec 2008 09:00:00 EST

BRANDON, FL--(Marketwire - December 1, 2008) - After careful consideration, the California Center for Advanced Dental Studies' (CCADS) board is excited to announce that Dr. Larry Saylor has been appointed as a Mentor Senior Instructor. "We are thrilled to have Dr. Saylor as a Mentor-Senior Instructor. He absolutely possesses all the qualities we look for. He's a premier clinician and an outstanding teacher," said Dr. Thomas Dudney, Program Director of CCADS.

Dr. Saylor's selection is the result of a rigorous selection process that includes an in-depth look at the doctor's collegiate and post-graduate education, clinical skills and overall integrity. In order to be selected, the dentist must have completed a minimum of 120 hours and three levels of advanced clinical training from accredited post-graduate programs. "What distinguishes our Mentors," comments Garrett Caldwell, President of CCADS, "is their comprehension and use of advanced clinical protocols for veneers inc

Pyng Medical Reports Record Sales of $6.5 Million in Fiscal 2008

Mon, 01 Dec 2008 09:00:00 EST

Pyng Achieves 36% Increase In Revenue over Fiscal 2007 and Gross Margin of 70%

Cardima Engages Western Medical as Distributor for Southern California, Arizona and Nevada Surgical & Electrophysiology Markets

Mon, 01 Dec 2008 08:45:00 EST

FREMONT, CA--(Marketwire - December 1, 2008) - Cardima, Inc. (OTCBB: CADM) has engaged Las Vegas-based Western Medical Inc. as a distributor for the Cardima Surgical Ablation System and the EP Pathfinder line of diagnostic catheters in the Southern California, Arizona and Nevada regions, including the Los Angeles, San Diego, Las Vegas, Phoenix and Tucson markets. Western Medical has a significant presence within the electrophysiology and surgical ablation community in these regions. The marketing program will commence immediately with the training of Western Medical's 35 field sales representatives.

Transaction in Own Shares

Mon, 01 Dec 2008 08:35:00 EST

BAGSVAERD, DENMARK--(Marketwire - December 1, 2008) - Novo Nordisk A/S - Share repurchase programme

On 15 August 2008 Novo Nordisk initiated its share repurchase programme in accordance with the provisions of the European Commission's regulation no 2273/2003 of 22 December 2003, also referred to as the Safe Harbour rules.

Under the programme Novo Nordisk will repurchase B shares for an amount of up to DKK 1.7 billion in the period from 15 August 2008 to 19 December 2008.

Since the announcement as of 24 November 2008, the following transactions have been made under the programme:

Daxor Announces Special Year-End Dividend

Mon, 01 Dec 2008 08:30:00 EST

NEW YORK, NY--(Marketwire - December 1, 2008) - Daxor Corporation (AMEX: DXR), a medical instrumentation and biotechnology company, today announced that The Board of Directors has voted to declare a special year-end dividend of $1.00 per share. The dividend will be paid to shareholders of record as of December 12, 2008. The dividend will be paid on Tuesday, December 30, 2008.

The Company previously paid quarterly dividends of $0.25 per share in 2008 on August 27th and November 26th. Prior to 2008, the Company last paid a dividend in 1996.

Somatic Systems, Inc. Launches New Website Phase 1

Mon, 01 Dec 2008 08:30:00 EST

NORTHAMPTON, MA--(Marketwire - December 1, 2008) - Somatic Systems, Inc. (PINKSHEETS: SMAS) is pleased to announce the launch of the first phase of their new website redesign at www.somatics.org. With a cleaner layout and simpler navigation design, the redesign is meant to provide a much more accessible and lucrative experience for visitors.

The upcoming second phase of the site's redesign will include a complete rewrite of most consumer information pages, significant enhancement of the site's styling as well as possible additional redesign work based on consumer testing data, further overhaul of the site's navigation and user interface, and increased content for maximal customer satisfaction -- including multimedia features such as the company's recent national television program.

On the Path Productions - Inspiring Greater Giving: The Power of Storytelling

Mon, 01 Dec 2008 08:00:00 EST

SAN FRANCISCO, CA--(Marketwire - December 1, 2008) - "The holiday season is a time of joy and giving, especially as we recognize the needs of others, yet our nonprofits and charitable giving clients are telling us how challenging the economy is," said Christopher Springmann, executive producer of On the Path Productions LLC. "Individual donations are down, and bequests, endowments and memorial gifts have seriously diminished. We're hearing the same old story from museums, hospitals, research groups and others who rely on underwriters: 'We just don't have the budget for that.'"

FONAR Granted Continued Listing by NASDAQ Panel

Mon, 01 Dec 2008 08:00:00 EST

MELVILLE, NY--(Marketwire - December 1, 2008) - FONAR Corporation (NASDAQ: FONR), the Inventor of MR ScanningT, today announced that The NASDAQ Listing Qualifications Panel ("NASDAQ Panel") has granted the Company's request for continued listing on The NASDAQ Capital Market, subject to the condition that, on or before January 15, 2009, the Company file a Current Report on Form 8-K with the Securities and Exchange Commission, evidencing the Company's compliance with the NASDAQ shareholders' equity requirement of $2.5 million, or demonstrating its compliance with one of the alternative listing criteria. While the Company is taking steps to comply with the terms of the NASDAQ Panel decision, there can be no assurance that the Company will be able to do so.

REMINDER: MAKOplasty(R) Robotic Arm Partial Knee Resurfacing -- A New Level of Precision

Mon, 01 Dec 2008 07:15:00 EST

OR-Live Webcast From St. Elizabeth Community Hospital: December 1, 2008, 3:00 PM PST

Auxilium Pharmaceuticals, Inc. Announces Distribution and License Agreement for Testim(R) in Europe With Ferring Pharmaceuticals

Mon, 01 Dec 2008 07:00:00 EST

MALVERN, PA and SAINT-PREX, SWITZERLAND--(Marketwire - December 1, 2008) - Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) and Ferring International S.A. today announced an exclusive agreement between them for the European distribution and license rights to Testim�, a proprietary, topical 1% testosterone once-a-day gel indicated for the treatment of hypogonadism.

"We are very pleased to have Ferring as our partner, given the strength of their European specialty urology and endocrinology franchises, their existing commercial infrastructure across Europe, and the successful track record they have established in commercializing differentiated products in the European Union," said Armando Anido, Chief Executive Officer and President of Auxilium. "This agreement enables us to bring our innovative testosterone replacement product to patients in all of the 15 countries where Testim has been approved and potentially in

Imaging3 CEO Opens RSNA 2008 Conference With New Images and Interview With Leading Trade Publication

Mon, 01 Dec 2008 07:00:00 EST

CHICAGO, IL--(Marketwire - December 1, 2008) - Imaging3T, Inc. (OTCBB: IMGG), developer of a breakthrough medical imaging device that produces 3D medical diagnostic images of virtually any part of the human body in real-time, announced the release of the company's newest imaging software at the 94th annual Radiological Society of North America (RSNA) conference and trade show.

Dean Janes, CEO of Imaging3, summarized the positive reception that Imaging3 and the Dominion Volumetric Imaging Scanner (DViS) received on the opening day of the conference in an interview with Merion Publications, Inc., a leading publisher of healthcare and medical imaging news for radiology professionals. "The publisher's interviews at RSNA are focused on new innovations that hold promise to dramatically improve patient care and safety and we are very gratified to be selected by Merion Publishing for these reasons," stated Mr. Janes.

DOR BioPharma Receives $1.5 Million From Sigma-Tau Pharmaceuticals for Exclusive Right to Negotiate orBec(R) Strategic Alliance

Mon, 01 Dec 2008 07:00:00 EST

EWING, NJ--(Marketwire - December 1, 2008) - DOR BioPharma, Inc. (OTCBB: DORB) ("DOR" or the "Company") announced today that it has received $1.5 million under a letter of intent with Sigma-Tau Pharmaceuticals, Inc. ("Sigma-Tau"), which grants Sigma-Tau an exclusive right to negotiate terms and conditions for a possible business transaction or strategic alliance regarding orBec� (oral beclomethasone dipropionate or oral BDP) and potentially other DOR pipeline compounds until March 1, 2009.

Americare Contracts for Phase 1 Patient Access Solutions' D-PAS Program to Handle Nursing Paperwork

Mon, 01 Dec 2008 06:00:00 EST

HAUPPAUGE, NY--(Marketwire - December 1, 2008) - Patient Access Solutions Inc. (OTCBB: PASO), a leading provider of healthcare/financial processing solutions for the healthcare, home care, nursing and dental industries, and The Americare Companies, one of New York's largest Home Healthcare agencies, today announced that they have signed an agreement to institute Patient Access Solutions' D-PAS digital solution for Americare's licensed home care services agency, Americare Inc.

JT 2149 / MPV Geared to Combining Boundary-Scan and Functional Tests

Mon, 01 Dec 2008 06:00:00 EST

JTAG Technologies Introduces New I/O Module

Register for BioPartnering North America (BPN) Now and Save CAD $450 Off the General Registration Rate

Mon, 01 Dec 2008 03:00:00 EST

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Dec. 1, 2008) - Technology Vision Group LLC (TVG) is pleased to announce the availability of the early registration rate for the 7th Annual BioPartnering North America (BPN) conference, to be held in Vancouver, B.C., Canada, on February 8-10, 2009. Register for BPN now at http://www.techvision.com/bpn/registration/ and save CAD $450 off the general registration rate. Pharmaceutical companies may also be eligible to receive two registrations for the price of one! Certain restrictions apply. Contact registration@techvision.com for details.

Pharming announces change in composition of Board Of Supervisory Directors

Mon, 01 Dec 2008 02:00:00 EST

LEIDEN, NETHERLANDS--(Marketwire - December 1, 2008) -

Leiden, The Netherlands, December 1, 2008. Biotech company Pharming Group NV ("Pharming" or "The Company") (Euronext: PHARM) announced today that Prof. Dr. B.P.Th. Veltman has notified the Company that he will retire from the Board of Supervisory Directors ("BOSD") effective December 1, 2008. Reaching the age of 76, Dr. Veltman had already previously announced that he had plans to retire from the BOSD at the Annual General Meeting in 2009. Personal circumstances have led him to take this decision at this moment.

Global Needlestick Prevention Group Honors Award Recipients as It Marks 7th Annual International Sharps Injury Prevention Awareness Month

Mon, 01 Dec 2008 01:00:00 EST

SALT LAKE CITY, UT--(Marketwire - December 1, 2008) - ISIPS, the first international sharps injury prevention group, announced that five recipients are being honored for reducing sharps injuries with a Sharps Injury Prevention Award with an additional 9 recipients receiving honorable mention awards. These awards are part of the International Sharps Injury Prevention Awareness Month activities being commemorated during December, 2008 starting with World AIDS Day, December 1st.

A number of very worthy individuals were nominated for the ISIPS 2008 International Sharps Injury Prevention Awards. Nominations were reviewed by a nominating committee, comprised of representatives from Terumo Medical, Covidien, Retractable Technologies Inc., Qlicksmart, Smartstream Pty Ltd, Managing Infection Control magazine and the International Sharps Injury Prevention Society (ISIPS). We are grateful to these organizations for sponsoring the awards this year.

TeraRecon Enhances PACS With iNtuition at RSNA 2008

Sun, 30 Nov 2008 09:12:00 EST

SAN MATEO, CA--(Marketwire - November 30, 2008) - TeraRecon, Inc. (www.terarecon.com), a leading provider of advanced visualization software, announced integration of the company's Aquarius iNtuition advanced visualization solution with many leading PACS vendors at the 94th Annual Meeting of the Radiological Society of North America (RSNA), held at McCormick Place, Chicago.

Picture Archiving and Communications Systems (PACS) are used for the storage, distribution and interpretation of radiological images in healthcare. PACS and teleradiology systems represent a fast-growing, multi billion dollar market globally.

Cryobanks International and Becoming Mom Pregnancy Spa & Ultrasound Imaging Center Team Up to Educate Moms About Umbilical Cord Blood

Sun, 30 Nov 2008 01:00:00 EST

ALTAMONTE SPRINGS, FL--(Marketwire - November 30, 2008) - Cryobanks International Inc., a leader in the collection, processing, and banking of umbilical cord blood, is pleased to announce its new partnership with Becoming Mom Pregnancy Spa & Imaging Center located in Mason, OH, a Cincinnati, OH suburb.

Through this partnership, Becoming Mom will add umbilical cord blood storage and donation to its long list of specialty services all which promote a healthy pregnancy for its clients. Becoming Mom will be taking an active role in educating their members about their cord blood options while in the comfort of the Becoming Mom Spa environment. Through this program, Becoming Mom Members will be able to donate their cord blood free of cost. Or if they feel private storage is the better option, their Becoming Mom Spa Membership will earn them a discount on Cryobanks International's initial processing and storage fee.

BioSyent Releases Financial Results-Third Quarter 2008

Fri, 28 Nov 2008 16:00:00 EST

MISSISSAUGA, ONTARIO,--(Marketwire - Nov. 28, 2008) - BioSyent Inc. ("BioSyent")(TSX VENTURE:RX) today released a summary of its financial results for the third quarter 2008. Sales decreased by 8.9% from $1,050,013 in first nine months of 2007 to $956,414 in first nine months of 2008. The company incurred a loss of ($118,363) in the first nine months of 2008 compared to a gain of $31,410 in first nine months of 2007. This loss is predominantly due to the higher pharmaceutical operating expenses for the establishment of the hospital division and the launch of Ciprofloxacin Injection, which was first shipped in May 2008.

Smith & Nephew Plc - Total Voting Rights

Fri, 28 Nov 2008 11:48:00 EST

LONDON, UK--(Marketwire - November 28, 2008) -


Smith & Nephew plc - Voting Rights and Capital

28 November 2008

In conformity with Rule 5.6.1 of the FSA's Disclosure
and Transparency Rules, we notify the market that as at 28
November 2008:

Smith & Nephew plc's issued share capital with voting rights consists
of 883,084,314 ordinary shares of US20c each.  

66,634,911 ordinary shares are held in treasury, and are not included
in the above figure.

883,084,314 ordinary shares may be used by shareholders for calculating
if they are required to notify their interest in, or change to their
interest in, the Company under the FSA's Disclosure and Transparency
Rules.

Paul Chambers
Company Secretary

                    This information is provided by RNS
          The company news service from the London Stock Exchange

END

Media Advisory: Fraser Institute Hosts Discussion on Canada's Aging and Outdated Medical Technology Inventory

Fri, 28 Nov 2008 11:00:00 EST

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Nov. 28, 2008) - Canada maintains the third most expensive universal access health care system in the developed world but Canadian patients continue to endure greater risks because the country's health care system regularly employs aging and outdated medical technology. Join Nadeem Esmail, Fraser Institute's director of health system performance studies, for a discussion on the state of Canada's medical technology and the need to restructure Canada's health care system to provide patients with better access to the latest medical technology.

FMX Ventures Inc.: Financial Statements and MD&A for the Three Months Ended September 30, 2008

Fri, 28 Nov 2008 10:44:00 EST

TORONTO, ONTARIO--(Marketwire - Nov. 28, 2008) - FMX Ventures Inc (NEX BOARD:FMX.H) formerly operating as Footmaxx Holdings Inc., ("Footmaxx"), a leading orthorpaedic and diagnostic company announces that: As a result of sale of its orthotics business in November, 2007, the only remaining material assets of the Company are its tax loss carryforwards and its listing and status as a reporting issuer. Accordingly, the board of directors initiated a process to determine the marketable value of the tax losses and reporting issuer status pursuant to which a wide range of entities, including legal, tax, financial and consulting firms, have been solicited to determine their interest in potentially acquiring the benefit of the Company's tax losses and reporting issuer status. Based on feedback from these entities, the board intends to establish a formal process to evaluate any proposals which are received in order to maximize value to shareholders generally. The Company has received certain

BC High School Students Empowered to Save Lives!

Fri, 28 Nov 2008 09:02:00 EST

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Nov. 28, 2008) - The ACT Foundation, in partnership with the British Columbia Ambulance Service and the Ambulance Paramedics of British Columbia - CUPE Local 873, is thrilled to announce that 6,500 students in three BC school districts will be empowered to save lives each year, thanks to the Envision Credit Union Charitable Foundation. "I congratulate the ACT Foundation and their partners for promoting healthy living while empowering students to save lives," said Mary Polak, Minister of Healthy Living and Sport. "CPR is a life saving skill that I would encourage all British Columbians to learn."

Theralase Technologies Announces 2008 Third Quarter Results 3Q Revenue Increased by 32% Year-Over-Year

Fri, 28 Nov 2008 09:00:00 EST

TORONTO, ONTARIO--(Marketwire - Nov. 28, 2008) - Highlights - Total 3Q 2008 sales increased by 32% to $459,789, compared to $347,580 in 3Q 2007 - Canadian product sales in 3Q 2008 (66% of total sales) rose by 72% year-over-year - US product sales in 3Q 2008 (25% of total sales) decreased by 32% year-over-year - Delivered a proprietary light system to be tested, in conjunction with Theralase's patented photodynamic compounds, in the destruction of additional cancer cell lines - Independent scientific research demonstrated Theralase's superiority for its proprietary laser technology

Open EC Technologies, Inc. Reports Record First Quarter, Fiscal 2009 Results With 49% Revenue Increase

Fri, 28 Nov 2008 09:00:00 EST

NORTH VANCOUVER, BRITISH COLUMBIA--(Marketwire - Nov. 28, 2008) - Open EC Technologies, Inc. (the "Company") (TSX VENTURE:OCE) announced today a new sales record with sales revenue for the first fiscal quarter increasing 49% from the same period of the previous fiscal year to $1,918,370 with EBITDA earnings of $222,431 for the period ended September 30, 2008. Highlights of the performance during the three months ended September 30, 2008 are as follows: - The revenues for the quarter were $1,918,370 with an EBITDA of $222,431 as compared with revenues of $1,286,584 and an EBITDA of $176,037 during the same period in the last fiscal year.

Acceleware Corp. Announces Third Quarter Results

Fri, 28 Nov 2008 07:00:00 EST

CALGARY, ALBERTA--(Marketwire - Nov. 28, 2008) - Acceleware Corp. (the "Corporation" or "Acceleware") (TSX VENTURE:AXE) reported today its financial results for the period ended September 30, 2008. /T/ Third Quarter 2008 Financial Highlights 3 months ended 3 months ended 9 months ended 9 months ended Sep 30, 2008 Sep 30, 2007 Sep 30, 2008 Sep 30, 2007 Revenue $ 472,620 $ 644,023 $ 2,900,910 $ 1,606,924 Net Loss $ 3,108,208 $ 1,795,667 $ 8,181,266 $ 4,616,323 L

Avis aux m�dias : Journ�e mondiale du sida 2008 - Une s�rie de conf�rences de M�decins du Monde Canada

Fri, 28 Nov 2008 06:30:00 EST

MONTREAL, QUEBEC--(Marketwire - 28 nov. 2008) - Le docteur Marie Gessy Richard, coordinatrice g�n�rale des projets de M�decins du Monde Canada en mati�re de lutte au VIH/sida en Ha�ti et en R�publique Dominicaine, sera de passage � Montr�al du 1er au 5 d�cembre prochain. Tout au long de son s�jour au Qu�bec, le docteur Gessy Richard donnera une s�rie de conf�rences portant sur l'int�gration des soins en milieu hospitalier pour les personnes s�ropositives vivant dans les pays en d�veloppement. Elle s'inspirera de son exp�rience � Cit� Soleil, en Ha�ti.

Medipattern Reports First Quarter Results for Fiscal 2009

Fri, 28 Nov 2008 06:00:00 EST

TORONTO, ONTARIO--(Marketwire - Nov. 28, 2008) - Attention: Business/Financial Editors: The Medipattern Corporation ("Medipattern") (TSX VENTURE:MKI), a pioneer in the development of medical software solutions that help improve imaging workflow and productivity, today announced its business highlights and unaudited financial results for the first quarter of fiscal 2009 ended September 30, 2008. Jeff Collins, CEO of Medipattern stated, "During the first quarter, we focused on finalizing the enhanced versions of B-CAD for fall release and its introduction at the upcoming Radiological Society of North America (RSNA) convention. Medipattern is very pleased to be featured in the GE Healthcare pavilion this year at RSNA as well as our own booth, 5875. We will be showcasing a fully digital ultrasound workflow designed to embrace consistent organized communication that is comprehensive and easy to use. The system is fully compliant with the American College of Radiology (ACR) Breast

MoneyTV, Week of 11/28

Fri, 28 Nov 2008 05:00:00 EST

LOS ANGELES, CA--(Marketwire - November 28, 2008) - MoneyTV is the nationally syndicated television program all about money and what makes it happen, (http://www.moneytv.net), featuring informative interviews by anchor Donald Baillargeon with company CEOs, providing insights into their operations and outlooks for their futures.

Free information packages from the featured companies can be requested by sending an email to info@moneytv.net.

Cannasat Therapeutics Reports Results for the Nine Months Ended September 30, 2008

Thu, 27 Nov 2008 17:30:00 EST

TORONTO, ONTARIO--(Marketwire - Nov. 27, 2008) - Cannasat Therapeutics Inc. (TSX VENTURE:CTH), a CNS (Central Nervous System) drug development company, today announced its results for the nine months ended September 30, 2008. OPERATIONAL HIGHLIGHTS - Completed work with IntelGenx Corp. to refine CAT 310 prototype formulations. CAT 310 is a potential treatment for patients with neuropathic pain, nausea/vomiting and other conditions, and is on track to commence Phase 1(b) clinical testing in Q1 2009.

Ergorecherche communique ses r�sultats financiers du premier trimestre 2009

Thu, 27 Nov 2008 13:09:00 EST

MONTREAL, QUEBEC--(Marketwire - 27 nov. 2008) - Ergorecherche Lt�e "Ergorecherche" (TSX CROISSANCE:ERG) annonce les r�sultats financiers de son premier trimestre 2009. Ergorecherche poursuit sa lanc�e et annonce un b�n�fice net de 62 590$ pour le premier trimestre de l'ann�e financi�re 2009. Les ventes ont progress� de 24,5% en comparaison avec le m�me trimestre l'ann�e derni�re, pour se situer � 612 127$. Ergorecherche a v�cu un retournement complet de situation depuis les derni�res ann�es, annon�ant des ann�es record cons�cutives. En effet, la soci�t� a annonc� des profits net de 423 247$ au 30 juin 2008, 210 111$ au 30 juin 2007 et de 159 502$ au 30 juin 2006. La soci�t� avait auparavant b�n�fici� de travaux de recherches importants pour lancer ses technologies brevet�es.

Ergoresearch Discloses First Quarter 2009 Financial Results

Thu, 27 Nov 2008 13:08:00 EST

MONTREAL, QUEBEC--(Marketwire - Nov. 27, 2008) - Ergoresearch Ltd "Ergoresearch" (TSX VENTURE:ERG) Ergoresearch continues the achievement of its business plan, by announcing profits of $62 590 for the first quarter of fiscal year 2009 compared to $21 236 for the same quarter last year. During this first quarter, sales amounted to $612 127, an increase of 24.5% compared to Q1-2008. Ergoresearch has witnessed a complete turnaround, delivering record years for the last years with profits of $423 247 for the year ended June 30, 2008, of $210 111 for the year ended June 30, 2007, and of $159 502 for the year ended June 30, 2006. The Company previously benefited from important research to launch its patented technologies.

Precise Biometrics Receives Follow-up Order from Swisscom, at a Value of Over USD 300,000 (SEK 2.4 Million)

Thu, 27 Nov 2008 03:13:00 EST

LUND, SWEDEN--(Marketwire - November 27, 2008) -

Precise Biometrics has received an order from Swisscom worth SEK 2.4 million, which will be invoiced before the end of the year. The order is a follow-up order and comprises both keyboards with fingerprint sensors and licenses of Precise BioMatchT.

Swisscom has been using the biometric solution since 2006 and has several thousands of users already deployed. The software solution is based on Precise BioMatchT and utilizes Precise BioKeyboardT as well as laptop-integrated fingerprint sensors. The current order is being delivered and invoiced during the fourth quarter.

I-many Receives NASDAQ Notice of Non-Compliance

Wed, 26 Nov 2008 17:20:00 EST

EDISON, NJ--(Marketwire - November 26, 2008) - I-many, Inc. (NASDAQ: IMNY), a leading provider of contract management software and services for the enterprise, reported that on November 24, 2008, the Company received a NASDAQ Staff Determination indicating that the Company has not regained compliance with the minimum $35 million market value of listed securities requirement set forth in NASDAQ Marketplace Rule 4310(c)(3)(B) (the "Rule"). As a result, the Company's common stock would be subject to delisting unless the Company requests a hearing before the NASDAQ Listing Qualifications Panel (the "Panel"). I-many intends to request a hearing before the Panel. Consequently, I-many's common stock will remain listed on The NASDAQ Capital Market until the Panel renders a decision following the hearing. However, there can be no assurance that the Panel will grant I-many's request for continued listing.

Aperture Health Appoints Ambassador Kevin E. Moley to Board of Directors

Wed, 26 Nov 2008 13:18:00 EST

MISSION VIEJO, CA--(Marketwire - November 26, 2008) - Aperture Health, Inc. (OTCBB: APRE) announced today that Ambassador Kevin Moley, a former Deputy Secretary of the U.S. Department of Health and Human Services in President George H.W. Bush's administration, has joined the Board of Directors of Aperture Health. Ambassador Moley also served as Assistant Secretary for Management and Budget of the U.S. Department of Health and Human Services. During the Reagan Administration, Ambassador Moley was the Chief Federal Regulator of the HMO industry and also was the Associate Administrator of Operations for Medicaid and Medicare. Most recently Ambassador Moley served as United States Ambassador to the U.N. in Geneva from September 2001 until May of 2006.

Experts Discuss How Lessons Learned From British System of Foreign Aid Can Help Modernize and Improve Foreign Aid in the United States

Wed, 26 Nov 2008 12:10:00 EST

Panel Discussion Set for Wednesday, December 3, 3:30 to 5 PM, in Room 2200, Rayburn House Office Building, on Capitol Hill in Washington, D.C.

You Don't Have to Suffer From Morning Sickness

Wed, 26 Nov 2008 11:36:00 EST

Expectant Moms Can Stop the Nausea... Naturally

MedaSorb Technologies' Board Member, Edward Jones M.D., Elected President of the Renal Physicians Association

Wed, 26 Nov 2008 11:31:00 EST

MONMOUTH JUNCTION, NJ--(Marketwire - November 26, 2008) - MedaSorb Technologies Corporation (OTCBB: MSBT) is pleased to recognize the election of its Director, Edward Jones M.D. to President of the Renal Physicians Association. Dr. Jones is an attending physician at Albert Einstein Medical Center and Chestnut Hill Hospital as well as Clinical Professor of Medicine at Temple University Hospital. Dr. Jones is currently president elect and will officially take over as president in 2009.

ProMutual Group Announces Dividend for Massachusetts Dentists

Wed, 26 Nov 2008 10:43:00 EST

BOSTON, MA--(Marketwire - November 26, 2008) - Medical Professional Mutual Insurance Company ("ProMutual"), the parent company of ProMutual Group, recently announced a dividend for qualified Massachusetts dentists. This year's dividend is the fifth consecutive year the company has issued a dividend to dentists.

"We are pleased to once again offer Massachusetts dental policyholders a dividend," said Gregg L. Hanson, senior vice president of underwriting for ProMutual Group. "We have a strong record of controlling costs and losses. Ultimately, the policyholders reap the benefits of those efforts."

Somatic Systems, Inc. National Television Show Airings Begin

Wed, 26 Nov 2008 08:30:00 EST

NORTHAMPTON, MA--(Marketwire - November 26, 2008) - Somatic Systems, Inc. (PINKSHEETS: SMAS) is pleased to announce that the first airings of the upcoming national television show featuring the company and its proprietary Clinical Somatics pain relief system, clinics, products, and training programs will begin next week. The television program will be the largest exposure for the company and its services so far, increasing Somatic Systems' audience from a population of tens of thousands to tens of millions.

Intrinsyc Announces "Symbian Ready" Location-Based Services Validation for Its Destinator Navigation Software

Wed, 26 Nov 2008 08:30:00 EST

Destinator one of the first LBS applications to be certified as "Symbian Ready" in Symbian technology validation program

Pharming announces positive results from Prodarsan(R) Phase I Study

Wed, 26 Nov 2008 08:05:00 EST

LEIDEN, NETHERLANDS--(Marketwire - November 26, 2008) -

Key step in clinical program for ageing diseases

Leiden, The Netherlands, November 26, 2008. Biotech company Pharming Group NV ("Pharming") (NYSE Euronext: PHARM) announced today that its wholly owned subsidiary DNage has successfully completed a Phase I trial, in healthy human volunteers, to evaluate the pharmacokinetics and tolerability of Prodarsan�.

In this Phase I study, single and multiple escalating doses were administered to healthy volunteers. The data obtained show that Prodarsan� is safe and well tolerated when used in dosages that have earlier shown to yield positive effects in preclinical studies. Since Prodarsan� will be used as an oral, liquid formulation the effects of food intake on absorption and elimination of the product were also investigated. Based on these data, combined with data generated in the preclinical program, an oral dosing scheme has been

MorphoSys and Galapagos enter alliance to co-develop novel therapeutic antibodies in bone & joint disease

Wed, 26 Nov 2008 01:40:00 EST

MECHELEN, BELGIUM--(Marketwire - November 26, 2008) - Combination of proprietary drug targets and unique technologies to create range of new therapeutic antibodies.

Click here to access the live audio webcast presentation at 14.00 CET/8:00 AM EST, call number +32.2.401.53.06, or toll free from the US 1.866.931.1567

Mechelen, Belgium and Munich, Germany; 26 November 2008 - Galapagos NV (Euronext: GLPG) and MorphoSys AG (FSE: MOR) announced today the launch of a long term co-development alliance aimed at discovering and developing antibody therapies based on novel modes of action in bone & joint disease, including rheumatoid arthritis, osteoporosis and osteoarthritis.

LAC+USC Healthcare Network CEO Talks on Palliative Care's Bottom Line Effects

Tue, 25 Nov 2008 18:26:00 EST

LOS ANGELES, CA--(Marketwire - November 25, 2008) - Pete Delgado, Chief Executive Officer, LAC+USC Healthcare Network, will deliver a speech "Palliative Care and its Bottom Line Effects" to TOWN HALL Los Angeles at the Omni Los Angeles Hotel on Thursday, December 11, 2008. The event marks the last in a series sponsored by the California HealthCare Foundation.

Palliative care is comprehensive, interdisciplinary care that focuses on promoting quality of life for patients living with serious, chronic, or terminal illness, as well as emotional support for their families. The proportion of hospitals with palliative care programs has more than doubled since 2000 to 53% of all facilities with more than 50 beds.

Medistem Suspends Filing Reports With Securities and Exchange Commission

Tue, 25 Nov 2008 18:03:00 EST

Decision Expected to Preserve Capital and Focus Efforts on Core Research and Development

Hansen Medical to Present at Upcoming Investor Conferences

Tue, 25 Nov 2008 14:51:00 EST

MOUNTAIN VIEW, CA--(Marketwire - November 25, 2008) - Hansen Medical, Inc. (NASDAQ: HNSN) announced today that it will be participating in upcoming investor conferences.

The company will be presenting at the 20th Annual Piper Jaffray Healthcare Conference being held December 2-3, 2008 at the New York Palace Hotel. Chief Financial Officer, Steve Van Dick, will provide a general company overview on Wednesday, December 3, 2008 at 4:00 p.m. Eastern.

Alzheimer's Drug Discovery Foundation Funds Varinel to Develop Drugs for Neurodegenerative Disease

Tue, 25 Nov 2008 14:40:00 EST

NEW YORK, NY--(Marketwire - November 25, 2008) - The Alzheimer's Drug Discovery Foundation (ADDF) announced today that it provided a grant of $185,000 to Varinel, Inc., an emerging pharmaceutical company dedicated to developing drugs that can prevent neuronal degeneration and improve brain function. The grant will assist Varinel in advancing the preclinical development of its multifunctional lead compounds, VAR10300 (also known as M30).

VAR10300 was tested successfully in cellular and animal models of Alzheimer's Disease (AD) reducing oxidative damage to mouse brain cells caused by iron-catalyzed free radical reactions and providing novel neuroprotective activity. The compound also improves levels of neurotransmitters, supports the growth of new neurons, and prevents cell death in preclinical models.

A.M. Best Reaffirms ProMutual Group's A- (Excellent) Rating

Tue, 25 Nov 2008 12:46:00 EST

BOSTON, MA--(Marketwire - November 25, 2008) - One of the leading medical liability insurance companies in the Northeast, ProMutual Group, recently received its thirteenth consecutive A- (Excellent) rating from A.M. Best Company. The nation's most recognized insurance rating organization based its independent opinion on the company's financial history, overall capitalization, underwriting practices and conservative reserving practices.

"Thirteen uninterrupted years of an A- (Excellent) rating from A.M. Best Company is an outstanding accomplishment and one that we are very proud of," said Richard W. Brewer, president and CEO of ProMutual Group. "The reaffirmation of ProMutual Group's A.M. Best rating attests to the company's formidable strength and the success of its conservative management and underwriting practices. Looking ahead, we are committed to maintaining our financial stability and providing the high quality resources, services and protection healthcare providers have

The Jean Coutu Group Launches an On-Line Purchasing Service

Tue, 25 Nov 2008 11:48:00 EST

A first on www.jeancoutu.com!

Le Groupe Jean Coutu lance un service d'achats en ligne

Tue, 25 Nov 2008 11:48:00 EST

Une premi�re sur www.jeancoutu.com !

Medline Announces Launch of MediClip Sterile O.R. Clipper

Tue, 25 Nov 2008 11:41:00 EST

New Close-Shave Foil Attachment Also Introduced as Part of Expanded Product Line

Are You One of the 260 Million Americans Who Needs Flu Vaccine?

Tue, 25 Nov 2008 11:00:00 EST

National Influenza Vaccination Week Is December 8-14